Skip to main content
Premium Trial:

Request an Annual Quote

Greg Summe, Robert Friel

Premium
Greg Summe, the former president and CEO of PerkinElmer, saw his total compensation increase 52 percent in 2007, according to the company’s proxy statement filed with the US Securities and Exchange Commission last week.
 
In 2007, Summe made $11 million, up from $7.2 million in 2006. Included in his 2007 compensation was a base salary of $1 million, stock awards of nearly $1.6 million and stock option awards of almost $1.7 million.
 
Until Aug. 1, Summe had been president of PerkinElmer. He served as CEO of the company through 2007.
 
His successor to both posts, Robert Friel, saw his total compensation increase 57 percent to $5.1 million in 2007 from $3.2 million in 2006. He became president and COO of the company in August at which time his base salary increased to $700,000. He was appointed president and CEO on Feb. 1.
 

For the entirety of 2007, Friel’s base salary was $631,923. His compensation package also included $955,541 in stock awards and $791,737 in stock options.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.